Unité de Fabrication des Médicaments S.A
Informe acción BVMT:UMED
Capitalización de mercado: د.ت231.7m
Unité de Fabrication des Médicaments Dirección
Dirección controles de criterios 0/4 Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Ridha Charfeddine
Chief Executive Officer (CEO)
Porcentaje del salario del CEO n/a Permanencia del CEO 4.4yrs Participación del CEO n/a Permanencia media de la dirección sin datos Promedio de permanencia en la Junta Directiva sin datos
Actualizaciones recientes de la dirección
Unité de Fabrication des Médicaments S.A, Annual General Meeting, Jun 28, 2024 May 31
Mostrar todas las actualizaciones
Consensus EPS estimates fall by 15% Sep 27
Now 20% undervalued after recent price drop Jul 01
Consensus EPS estimates increase by 37% Jun 29
New minor risk - Financial position Jun 24
Full year 2023 earnings released Jun 22
Unité de Fabrication des Médicaments S.A, Annual General Meeting, Jun 28, 2024 May 31
Price target increased by 8.0% to د.ت12.10 May 28
New minor risk - Financial data availability Apr 20
New major risk - Revenue and earnings growth Oct 30
New major risk - Revenue and earnings growth Oct 10
Upcoming dividend of د.ت0.47 per share at 5.8% yield Jul 24
Price target increased by 8.9% to د.ت11.00 Jun 07
Price target increased by 21% to د.ت10.30 May 03
Price target increased to د.ت8.20 Nov 16
Consensus EPS estimates fall by 72% Sep 24
First half 2022 earnings released: EPS: د.ت0 (vs د.ت0.16 in 1H 2021) Sep 15
Price target increased to د.ت10.20 Jul 08
Full year 2021 earnings: Revenues in line with analyst expectations Jun 15
Price target decreased to د.ت8.45 Nov 25
Upcoming dividend of د.ت0.47 per share Jun 23
New 90-day low: د.ت8.59 Feb 12
New 90-day low: د.ت9.32 Jan 25
New 90-day low: د.ت9.50 Jan 05
New 90-day low: د.ت9.73 Dec 07
New 90-day high - د.ت9.90 Sep 03
Ridha Charfeddine and others acquired 6.85% stake in Unité de Fabrication des Médicaments (BVMT:UMED) from SQM Frontier Africa Master Fund, Ltd., managed by SQM Frontier Management, LP. Sep 02
New 90-day high - د.ت9.80 Aug 07
Price target lowered to د.ت12.60 Aug 06
CEO Mr. Ridha Charfeddine is the Chief Executive Officer at Unité de Fabrication des Médicaments since June 12, 2020. He is the President of the Board of Directors at Société UNIMED.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}